UNM Comprehensive Cancer Center Opens Lung Cancer Screening Clinic

Ablation Is Safe and Effective for Stage I-II Non-Small Cell Lung Cancer With Interstitial Lung Disease

RSNA Margulis Award Honors AI Tool for Pancreatic Cancer Detection

AI Technique for MRI May Guide Real-Time Glioblastoma Treatment

Lung Cancer Screening Significantly Increases Long-Term Survival

AMA Includes New CPT Code for Use of Unfold AI in Prostate Cancer Care

Theranostics Study Targets Glypican-1 in Pancreatic Ductal Adenocarcinoma

Philips, Quibim to Collaborate on AI-enabled MR Prostate Imaging and Reporting Solution

Mayo Develops AI Model for Earlier Detection of Pancreatic Cancer With CT

In Nasopharyngeal Carcinoma, Larger Lymph Node Threshold Optimizes Outcomes

POSLUMA PET May Help Guide Prostate Treatment Decisions in Men With Biochemical Recurrence and Low PSA Levels

No Significant Difference in Prostate Cancer Upgrade, Downgrade Rates Between PI-RADS 2.0 and 2.1

New Radioimmunotherapy Cures Epithelial Ovarian Cancer in a Preclinical Study

Periventricular Schwannoma

By Hlis R, Kalathuru C, Rodriguez A, Khalaj K, Bindal S, Honarpisheh P, Shah MN, Bhattacharjee M, Riascos R

Bilateral Germ Cell Neoplasia In Situ with Left Testicular Seminom

By Hwang J, Alexander LF

Percutaneous and Transvenous Liver Biopsy

By Sterabadi AHM, Anbari H, Khaja MS, Kapoor BS

Consensus Recommendations Released for PET/MRI in Oncology

Screening MRI With PSA Improves Prostate Cancer Diagnosis

NIH Releases Proteogenomic Dataset for Cancer Research

PSMA PET/CT Diagnoses Prostate Cancer Without Biopsy in Elderly Patients

New Process Improves Production of Short-Lived Scandium Radioisotopes

Theranostic Prostate Cancer Trial Escalates Dose

PSMA PET Provides Better Prediction of Prostate Cancer Recurrence Than Standard of Care

Sociodemographic Factors Impact CTC Screening Among Medicare Beneficiaries

First Patient Dosed in Combined Targeted Radiation Therapy and DNA Inhibitor Clinical Trial

Synoptic Reports Improve Pretreatment CT in Advanced Ovarian Cancer Patients

Prostate Cancer Patient Outcomes Improve With Personalized Dosing

Newly Discovered Theranostic Agent Targets Multiple Cancer Types

Radiotracer Identifies, Characterizes Renal Cell Carcinomas

Radiopharmaceutical Therapy Target Discovered for Metastatic Bladder Cancer

SNMMI Image of the Year: Novel Theranostic Pair Detects, Visualizes Targeted Treatment of Pancreatic Cancer

SNMMI Abstract of the Year: Dosing With Iomab-B Enables Marrow Transplantation with Long-Term Survival in AML

Paper Addresses Challenges, Opportunities in Theranostics Education

Pretherapy Imaging and Dosimetry Personalizes Treatment Planning for Thyroid Cancer Patients

GE HealthCare Collaborates With Canadian Healthcare Institutions on Theranostics Center of Excellence

POSLUMA for PSMA PET Imaging Now Commercially Available in the US

First Patient Dosed in Telix’s STARBURST Study

Scientists Develop Method to Visualize Proton Beam Trajectory Using MRI

First Clinical Trial of 18F-CD8 PET for Monitoring Immunotherapy Response Starts

IMAGIO Consortium Receives EUR 24 Million Grant to Improve Cancer Treatments